The central processing unit or CPU is a fundamental component of any personal computer enabling the efficient processing of data between all other involved network components (certainly someone can correct me here). In a sense, so is CPU …
Continue reading “Quicky on Computershare (CPU). Hoping for a revisit”Tag: fundamental valuation
Quicky #18 on Globaltrans (GLTR LI)
Russia is a market segment shun by investors. It’s also a vast country. What better way to transport bulk by rail? …
Continue reading “Quicky #18 on Globaltrans (GLTR LI)”Quick update on Quadient (and a small buy)
After some news regarding Quadient I bought some shares recently.
Continue reading “Quick update on Quadient (and a small buy)”Quicky #15 on Teva
This is part #15 about Teva, the huge Israeli generics producer.
Continue reading “Quicky #15 on Teva”Quicky #14 on Koshidaka (2157 JP)
This is part #14 about Koshidaka Holdings, which business mostly consists of karaoke services in its domestic Japan market.
Continue reading “Quicky #14 on Koshidaka (2157 JP)”Quicky on BBBY (Q3 2020)
Jan 7th, Bed Bath & Beyond (BBBY US) reported its Q3 results for three months ending Nov 2020.
Continue reading “Quicky on BBBY (Q3 2020)”I looked at the Banking Industry and I invested in this Asian company! (Silverlake)
This is part six and at the same time the last piece of my series on banks, for the time being. In this post I will do a quick recap of the series and take a look at my learnings.
More important for you: I analysed a company I had on my to-do-list for some time now …
Continue reading “I looked at the Banking Industry and I invested in this Asian company! (Silverlake)”Quicky #6 on Svenska Handelsbanken
This is part two of my mini series on banks and part #6 within my series of Quickies on new companies.
Continue reading “Quicky #6 on Svenska Handelsbanken”Quicky #5 on Gilead
This is part #5 on Gilead Sciences, Inc. of which I own shares (GILD US) since a few years without doing a thorough company analysis so far. The share price of GILD saw a recent high of $84 on remdesivir hopes in late April, but is now at a multi-year low of $60. Time for me to take a look …
Continue reading “Quicky #5 on Gilead”Quicky #4 on Inpex (1605 JP)
This is part #4 about Inpex Corporation (1605 JP). I stumbled about the company when reading about Royal Dutch Shell’s huge Prelude FLNG project off Australia in which Inpex owns a stake with several other Asian companies. Inpex took a huge one-off charge due to operational production problems depressing current earnings. Time to take a look …
Continue reading “Quicky #4 on Inpex (1605 JP)”Is Tencent Music (TME) worth buying for its massive long-term growth potential?
[This post was published with password protection on Sept 22 but is now reposted without protection] Spotify is a very well known company in Western Europe and the US. Chances are that you use either Spotify’s services or any other service from Apple, Google, Amazon, etc! Spotify’s investing story rides on the huge secular growth trend of music streaming and podcasts, accelerated through covid-19, resulting in its one year stock price performance of +60%. Spotify’s profitability might be an issue, though. But there might be a more profitable alternative for investors …
Continue reading “Is Tencent Music (TME) worth buying for its massive long-term growth potential?”Quicky #3 on L’Occitane
This is part # about one of my smaller ‘legacy positions’ which I bought into without a deeper analysis. As many retailers the company was and is strongly impacted by the pandemic. Time for a quicky (which got a bit longer) …
Continue reading “Quicky #3 on L’Occitane”